Encore abstracts(abstracts previously presented at another conference or previously published in a journal) will not be considered. Dear Colleagues, We are pleased to invite you to join us at the 2024 International Congress of ILTS in Houston, Texas, USA, May 1-4, 2024. Liver Disease and Tr...
Encore abstracts(abstracts previously presented at another conference or previously published in a journal) will not be considered. Dear Colleagues, We are pleased to invite you to join us at the 2024 International Congress of ILTS in Houston, Texas, USA, May 1-4, 2024. Liver Disease and Tr...
This conference highlighted the theme “Exploring Innovations in Liver Health: From Research to Treatment” with the following scientific tracks: Hepatologists and Gastroenterologists Researchers and Scientists Surgeons and Transplant Specialists Oncologists ...
A consensus conference sponsored by the American Society of Transplant Surgeons (ASTS), American Society of Transplantation (AST), United Network for Organ Sharing (UNOS) and American Society of Nephrology (ASN) convened to examine simultaneous liver-kidney transplantation (SLK). Directors from the ...
Conference AbstractLate acute rejection of liver transplants: risk factors, treatment and resultsJ. ZiółkowskiL. PączekD. PorowskiU. OłdakowskaJedynakJ. SańkoResmerG. SenatorskiJ. WyzgałM. KrawczykP. NyckowskiK. Zieniewicz
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant. 2004;4(7):1033–41. Article CAS PubMed Google Scholar International working party. Terminology for hepatic allograft rejection. Hepatology. 1995;22(2):648–54. Google Scholar O’Leary JG,...
We read with interest "The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis"1, which strove to examine various aspects of early Liver Transplant (LT) for alcohol hepatitis (AH) by defining terms, outl... S Eswaran,E Chan - 《Liver Transplantation》 被引量: ...
Liver transplant (LT) has become the standard of care of end-stage liver disease (ESLD) or unresectable hepatocellular carcinoma. There are at least 18,000
Long term outcome of T3 down-staged candidates was poorer than that of MC candidates, particularly for cases not achieving down-staging. However, their survival outcome was significantly better than that achieved with non-transplant therapies.
The International Liver Transplantation Society held its yearly meeting as a joint conference with the European Liver and Intestine Transplant Association ... J Levitsky,O Guckelberger - 《Liver Transplantation》 被引量: 4发表: 2012年 Meeting report of the 2014 joint international congress of the ...